| |
| |
|
| Insider
Information: |
Henwood Geraldine |
| Relationship: |
President and CEO, Dir... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
229,001 |
|
|
Indirect Shares
|
50,014 |
|
|
| Direct
Value |
$249,231 |
|
|
|
Indirect Value
|
$55,000 |
|
|
| Total
Shares |
279,015 |
|
|
| Total
Value |
$304,231 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Map Pharmaceuticals Inc |
MAPP |
Director |
2013-02-28 |
0 |
2009-11-18 |
0 |
Premium* |
|
|
Alkermes Plc |
ALKS |
Director |
2014-01-15 |
0 |
2012-08-24 |
0 |
Premium* |
|
|
Societal CDMO, Inc |
SCTL |
Director |
2021-04-20 |
226,574 |
2021-04-20 |
50,000 |
Premium* |
|
|
Baudax Bio, Inc. |
BXRX |
President and CEO, Dir... |
2022-12-15 |
2,427 |
2022-12-15 |
14 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
57 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALKS |
Alkermes Plc |
Director |
• • – |
2012-08-24 |
4 |
OE |
$11.84 |
$236,800 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director |
• • – |
2012-08-24 |
4 |
AS |
$17.94 |
$358,842 |
D/D |
(20,000) |
0 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director |
• • – |
2012-08-27 |
4 |
AS |
$17.80 |
$355,990 |
D/D |
(20,000) |
0 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director |
• • – |
2012-08-27 |
4 |
OE |
$11.44 |
$228,800 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director |
• • – |
2013-08-29 |
4 |
AS |
$31.68 |
$633,532 |
D/D |
(20,000) |
0 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director |
• • – |
2013-08-29 |
4 |
OE |
$13.44 |
$268,800 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director |
• • – |
2014-01-15 |
4 |
AS |
$47.52 |
$1,902,765 |
D/D |
(40,000) |
0 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director |
• • – |
2014-01-15 |
4 |
OE |
$14.04 |
$616,200 |
D/D |
40,000 |
40,000 |
0 |
- |
|
| BXRX |
Baudax Bio, Inc. |
President and CEO |
• • – |
2019-12-05 |
4 |
A |
$0.00 |
$0 |
D/D |
323,958 |
353,868 |
0 |
- |
|
| BXRX |
Baudax Bio, Inc. |
President and CEO |
• • – |
2020-01-27 |
4 |
D |
$8.51 |
$42,984 |
D/D |
(5,051) |
367,887 |
0 |
- |
|
| BXRX |
Baudax Bio, Inc. |
President and CEO |
• • – |
2020-01-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,070 |
372,938 |
0 |
- |
|
| BXRX |
Baudax Bio, Inc. |
President and CEO |
• • – |
2020-12-05 |
4 |
D |
$1.14 |
$94,637 |
D/D |
(83,015) |
284,872 |
0 |
- |
|
| BXRX |
Baudax Bio, Inc. |
President and CEO |
• • – |
2021-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
65,435 |
350,307 |
0 |
- |
|
| BXRX |
Baudax Bio, Inc. |
President and CEO |
• • – |
2021-05-07 |
4 |
B |
$0.83 |
$4,992 |
D/D |
6,000 |
356,307 |
2.73 |
- |
|
| BXRX |
Baudax Bio, Inc. |
President and CEO |
• • – |
2021-09-22 |
4 |
B |
$0.59 |
$4,798 |
D/D |
8,200 |
364,507 |
2.73 |
- |
|
| BXRX |
Baudax Bio, Inc. |
President and CEO |
• • – |
2021-12-05 |
4 |
D |
$0.35 |
$3,204 |
D/D |
(9,155) |
355,352 |
0 |
- |
|
| BXRX |
Baudax Bio, Inc. |
President and CEO |
• • – |
2021-12-15 |
4 |
D |
$0.31 |
$5,777 |
D/D |
(18,636) |
336,716 |
0 |
- |
|
| BXRX |
Baudax Bio, Inc. |
President and CEO |
• • – |
2022-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
39,473 |
49,093 |
0 |
- |
|
| BXRX |
Baudax Bio, Inc. |
President and CEO |
• • – |
2022-12-15 |
4 |
B |
$2.55 |
$3,057 |
D/D |
1,200 |
2,427 |
2.73 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Director |
– • – |
2009-11-18 |
4 |
S |
$8.77 |
$142,444 |
D/D |
(16,250) |
0 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Director |
– • – |
2009-11-18 |
4 |
OE |
$0.64 |
$10,418 |
D/D |
16,250 |
16,250 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Director |
– • – |
2010-08-05 |
4 |
S |
$12.78 |
$153,407 |
D/D |
(12,000) |
0 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Director |
– • – |
2010-08-05 |
4 |
OE |
$0.74 |
$8,921 |
D/D |
12,000 |
12,000 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Director |
– • – |
2010-10-27 |
4 |
AS |
$15.65 |
$152,898 |
D/D |
(9,764) |
0 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Director |
– • – |
2010-10-27 |
4 |
OE |
$0.64 |
$16,229 |
D/D |
9,764 |
3,750 |
0 |
- |
|
57 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
